Ny L, Hernberg M, Nyakas M, Koivunen J, Oddershede L, Yoon M, et al. BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysis. AO [Internet]. 2020 Jul. 2 [cited 2024 Nov. 24];59(7):833-44. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24283